Practical guidelines for postmenopausal hormone therapy

Maturitas

Volumn 51, Issue 1, 2005, Pages 4-7

  Speroff, L ^a   Kenemans, P ^b   Burger, H G ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Breast cancer; Guidelines; Hormone therapy; Menopause; Osteoporosis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GESTAGEN; ORAL CONTRACEPTIVE AGENT; PHYTOESTROGEN; RALOXIFENE; TESTOSTERONE; TIBOLONE;

BLEEDING; BREAST CANCER; CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COLORECTAL CANCER; COMPREHENSION; CONFERENCE PAPER; CONFUSION; DRUG EFFECT; DRUG USE; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FRAGILITY FRACTURE; HEALTH CARE NEED; HORMONE SUBSTITUTION; HUMAN; ISCHEMIC HEART DISEASE; MEDICAL DECISION MAKING; MEDICAL DOCUMENTATION; MENOPAUSAL SYNDROME; NETHERLANDS; NONHUMAN; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRACTICE GUIDELINE; RECOGNITION; STROKE; VAGINA ATROPHY; VEIN THROMBOSIS;

ALZHEIMER DISEASE; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; PRACTICE GUIDELINES; PROGESTINS;

EID: 18844443933     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2005.02.006     Document Type: Conference Paper

References (0)